Welch, H. Gilbert
Welch, H. Gilbert, 1955-
H. Gilbert Welch American teacher
Welch, H. Gilbert, 19..-....
וולץ', ה. גילברט
VIAF ID: 164687247 (Personal)
Permalink: http://viaf.org/viaf/164687247
Preferred Forms
- 100 0 _ ‡a H. Gilbert Welch ‡c American teacher
-
- 100 1 _ ‡a Welch, H. Gilbert
-
-
- 100 1 _ ‡a Welch, H. Gilbert
- 100 1 _ ‡a Welch, H. Gilbert
-
-
- 100 1 _ ‡a Welch, H. Gilbert ‡d 1955-
- 100 1 _ ‡a Welch, H. Gilbert ‡d 1955-
- 100 1 _ ‡a Welch, H. Gilbert, ‡d 19..-....
-
-
-
-
4xx's: Alternate Name Forms (17)
Works
Title | Sources |
---|---|
Avoiding the unintended consequences of growth in medical care: how might more be worse? | |
Case-mix adjustment: making bad apples look good | |
Could distance be a proxy for severity-of-illness? A comparison of hospital costs in distant and local patients | |
Could more health care lead to worse health? | |
Current antibiotic therapy for isolated urinary tract infections in women | |
Davies and Welch draw unfounded conclusions about thyroid cancer from epidemiological data-reply | |
Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era. | |
Determining transition probabilities from mortality rates and autopsy findings. | |
Diagnosefalle wie Gesunde zu Kranken erklärt werden | |
Do increased 5-year survival rates in prostate cancer indicate better outcomes? | |
Doba jedová. | |
Dois-je me faire tester pour le cancer ? : peut-être pas et voici pourquoi | |
The drug facts box: providing consumers with simple tabular data on drug benefit and harm | |
Estimating the impact of adding C-reactive protein as a criterion for lipid lowering treatment in the United States | |
The exaggerated relations between diet, body weight and mortality: the case for a categorical data approach | |
Fee-for-data: a strategy to open the HMO black box. | |
Flawed inferences about screening mammography's benefit based on observational data | |
The frequency of Pap smear screening in the United States | |
The future of the Department of Veterans Affairs health care system | |
Group writing of letters to the editor as the goal of journal club | |
The heterogeneity of cancer | |
The impact of practicing in multiple hospitals on physician profiles | |
Is language a barrier to the use of preventive services? | |
Is this issue a mistake? | |
Know your chances : understanding health statistics | |
Less medicine, more health. | |
Let's make a deal. Negotiating a settlement between physicians and society | |
Machine Learning and the Cancer-Diagnosis Problem - No Gold Standard | |
A Markov model of early diagnosis | |
Méně medicíny - více zdraví | |
Misunderstandings about the effects of race and sex on physicians' referrals for cardiac catheterization. | |
The natural history of invasive breast cancers detected by screening mammography | |
A new scale for assessing perceptions of chance: a validation study | |
no2003033745 | |
Not so silver lining | |
Observational intensity bias associated with illness adjustment: cross sectional analysis of insurance claims | |
Overdiagnosed : making people sick in the pursuit of health | |
Overdiagnosis in cancer | |
Overstating the evidence for lung cancer screening: the International Early Lung Cancer Action Program (I-ELCAP) study. | |
Patients and medical statistics. Interest, confidence, and ability | |
Physician profiling. An analysis of inpatient practice patterns in Florida and Oregon | |
Prioritizing Oregon's hospital resources. An example based on variations in discretionary medical utilization | |
Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005 | |
Prostate cancer [VR] c2002: | |
Prostate-specific antigen levels in the United States: implications of various definitions for abnormal | |
Racial disparities in abdominal aortic aneurysm repair among male Medicare beneficiaries | |
The Rapid Rise in Cutaneous Melanoma Diagnoses | |
Ratio measures in leading medical journals: structured review of accessibility of underlying absolute risks | |
Reconsidering Prostate Cancer Mortality - The Future of PSA Screening | |
Regional Variation of Computed Tomographic Imaging in the United States and the Risk of Nephrectomy | |
Regional variations in health care intensity and physician perceptions of quality of care | |
Risk communication in clinical practice: putting cancer in context. | |
Risk for Complications After Transthoracic Needle Lung Biopsy | |
Risk for increased utilization and adverse health outcomes among men served by the Veterans Health Administration | |
The risk of death by age, sex, and smoking status in the United States: putting health risks in context | |
The role of patients and providers in the timing of follow-up visits. Telephone Care Study Group | |
Screening for disease | |
Setting the revisit interval in primary care | |
Should I be tested for cancer? maybe not and here's why | |
Le surdiagnostic : rendre les gens malades par la poursuite de la santé | |
Surgical mortality as an indicator of hospital quality: the problem with small sample size | |
Thyroid cancer survival in the United States: observational data from 1973 to 2005. | |
Tobacco money: up in smoke? | |
Traquer la maladie : les dérives contemporaines du dépistage des maladies | |
Trends in diagnostic testing following a national guideline for evaluation of dyspepsia | |
Trends in Metastatic Breast and Prostate Cancer--Lessons in Cancer Dynamics | |
Trends in the use of the pulmonary artery catheter in the United States, 1993-2004. | |
U.S. trends in CABG hospital volume: the effect of adding cardiac surgery programs | |
Uncoupling Diagnosis and Treatment of Incidentally Imaged Renal Masses-Reply | |
US women's attitudes to false-positive mammography results and detection of ductal carcinoma in situ: cross-sectional survey | |
The use of Medicare home health care services | |
Using a drug facts box to communicate drug benefits and harms: two randomized trials | |
Using autopsy series to estimate the disease "reservoir" for ductal carcinoma in situ of the breast: how much more breast cancer can we find? | |
The value of benefit data in direct-to-consumer drug ads. | |
Variation in the tendency of primary care physicians to intervene | |
When should this patient be seen again? | |
Why estimates of physician supply and requirements disagree | |
Women's perceptions of breast cancer risk: how you ask matters | |
Women's understanding of the mammography screening debate | |
Women's views on breast cancer risk and screening mammography: a qualitative interview study. | |
אבחון יתר : כיצד המרדף אחרי הבריאות מייצר חולים | |
과잉진단 건강검진의 불편한 진실 | |
病気の「数字」のウソを見抜く : 医者に聞くべき10の質問 | |
過剰診断 : 健康診断があなたを病気にする |